Alain Labrique: How We Can Better Integrate AI into the Design and Execution of Clinical Trials
Alain Labrique, Director of Department of Digital Health and Innovation at World Health Organization, posted on LinkedIn:
“Proud to share our latest piece in The Lancet Group Digital Health on how we can better integrate AI into the design and execution of clinical trials.
Too often, we see high-potential AI tools fail to translate into meaningful clinical impact—not because the algorithms don’t work, but because they’re not embedded in real-world contexts. In this paper, we propose the AI–Healthcare Integration Framework (AI-HIF)—a structured approach to guide the responsible, effective use of AI in trials.
This isn’t about chasing hype. It’s about asking:
- Are we designing with end-users in mind?
- Are we validating across diverse populations?
- Are we planning for real deployment, monitoring, and governance?
At WHO, we’re committed to helping countries adopt AI that is ethical, evidence-based, and equitable. I hope this contribution supports the global conversation on how to move from pilots to scalable, trustworthy systems.”
Title: Artificial intelligence and clinical trials: a framework for effective adoption
Authors: Bilal A Mateena, Vasee Moorthyc, Alain Labriquec, Jeremy Farrarc
Read the Full Article.
More posts featuring Alain Labrique.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023